Behrends, Czarina Navos

Publications

Sort by

Co-Author Network

selected publications

Legal Barriers to Safer Smoking Supplies Cause Harm and Should Be Removed. The Milbank quarterly. 2025 Academic Article GET IT
Correction: Study assessing the effectiveness of overdose prevention centers through evaluation research (SAFER): an overview of the study protocol. 2025 GET IT
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York City. Journal of urban health : bulletin of the New York Academy of Medicine. 2025 Academic Article GET IT
"New Normal:" Opportunities and Challenges Faced by Syringe Service Programs Following the Effects of the COVID-19 Pandemic. Substance use & misuse. 2025 Academic Article GET IT
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States. Addiction (Abingdon, England). 2024 Academic Article GET IT
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement. JAMA network open. 2024 Academic Article GET IT
High Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among Urban Syringe Service Program Participants. Substance use & addiction journal. 2024 Academic Article GET IT
The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study. Harm reduction journal. 2023 Academic Article GET IT
NEXT: description, rationale, and evaluation of a novel internet-based mail-delivered syringe service program. Journal of substance use. 2022 Academic Article GET IT
Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island. JAMA network open. 2022 Academic Article GET IT
Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts. Drug and alcohol dependence. 2022 Academic Article GET IT
Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021. Public health reports (Washington, D.C. : 1974). 2022 Academic Article GET IT
Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. The International journal on drug policy. 2022 Academic Article GET IT
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine. Journal of addiction medicine. 2022 Academic Article GET IT
Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm reduction journal. 2022 Academic Article GET IT
M²HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID. Trials. 2022 Academic Article GET IT
Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction (Abingdon, England). 2022 Academic Article GET IT
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug and alcohol dependence. 2022 Academic Article GET IT
The Experience of Implementing a Low-Threshold Buprenorphine Treatment Program in a Non-Urban Medical Practice. Substance use & misuse. 2021 Academic Article GET IT
Community-based Naloxone Coverage Equity for the Prevention of Opioid Overdose Fatalities in Racial/Ethnic Minority Communities in Massachusetts and Rhode Island. Addiction (Abingdon, England). 2021 Academic Article GET IT
Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities. AIDS (London, England). 2021 Academic Article GET IT
Human Immunodeficiency Virus transmission by HIV risk group and along the HIV care continuum: A contrast of six US cities. Journal of acquired immune deficiency syndromes (1999). 2021 Academic Article GET IT
Costs of opioid overdose education and naloxone distribution in New York City. Substance abuse. 2021 Academic Article GET IT
Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies. The International journal on drug policy. 2021 Academic Article GET IT
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. The International journal on drug policy. 2021 Academic Article GET IT
Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. The lancet. HIV. 2021 Academic Article GET IT
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City. Journal of urban health : bulletin of the New York Academy of Medicine. 2021 Academic Article GET IT
Times cited: 4
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Academic Article GET IT
Times cited: 35
A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study. Journal of general internal medicine. 2021 Academic Article GET IT
Times cited: 31
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities. The Journal of infectious diseases. 2020 Academic Article GET IT
Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward. Medical decision making : an international journal of the Society for Medical Decision Making. 2020 Editorial Article GET IT
Times cited: 4
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis. The International journal on drug policy. 2020 Academic Article GET IT
Times cited: 2
Ending the HIV epidemic in the USA: an economic modelling study in six cities. The lancet. HIV. 2020 Academic Article GET IT
Times cited: 47
The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities. AIDS (London, England). 2020 Academic Article GET IT
Times cited: 32
Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities. Medical decision making : an international journal of the Society for Medical Decision Making. 2019 Academic Article GET IT
Times cited: 28
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019 Academic Article GET IT
Times cited: 22
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Journal of substance abuse treatment. 2019 Academic Article GET IT
Times cited: 5
A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination. Journal of public health management and practice : JPHMP. 2019 Academic Article GET IT
Times cited: 5
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA. The International journal on drug policy. 2019 Academic Article GET IT
Times cited: 7
Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. Journal of acquired immune deficiency syndromes (1999). 2018 Letter GET IT
Times cited: 22
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs. Drug and alcohol dependence. 2018 Academic Article GET IT
Times cited: 24
Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities. Substance use & misuse. 2017 Academic Article GET IT
Times cited: 13
Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012. MMWR. Morbidity and mortality weekly report. 2016 Academic Article GET IT
Times cited: 10

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Expansion of Mail-Delivered Harm Reduction Services in the U.S. awarded by National Institute on Drug Abuse Principal Investigator 2022 - 2025

DAT-18-06 Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) awarded by National Institute on Drug Abuse Co-Investigator 2019 - 2025
missing activity Co-Investigator 2020 - 2024
missing activity Co-Investigator 2019 - 2024

Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE) awarded by National Institute on Drug Abuse Principal Investigator Subaward 2024 - 2028
Understanding the short- and long-term effects of the COVID-19 pandemic on the overdose crisis awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2023 - 2028
A comparative evaluation of overdose prevention programs in New York City and Rhode Island awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2023 - 2027
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations awarded by National Heart, Lung, & Blood Institute Principal Investigator Subaward 2020 - 2025
missing activity Principal Investigator Subaward 2017 - 2023
missing activity Principal Investigator Subaward 2020 - 2022

more ...

less ...

Background

education and training

Ph.D., University of California, Davis 2014
M.P.H., University of California, Davis 2010
B.A., University of San Diego 2005

Contact

full name

Czarina Navos Behrends

primary email

czb2002@med.cornell.edu

VIVO Weill Cornell Medical College

Czarina Navos Behrends Assistant Professor of Population Health Sciences

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email